Patchtek’s transdermal cannabis patch is currently under development. The patch will have the option of dosage rates and length of delivery of the cannabinoids being utilized.

Previous samples were tested on the human body with conclusive results in the instance that the cannabinoids were absorbed into the blood stream in a relatively short period of time.

The design being implemented utilizes current market technology and delivery mechanisms to provide a fast, responsive ailment that can be utilized to treat conditions associated with cancer, chemotherapy, AIDS, Athritis and rheumatism, glaucoma, spasticity, multiple sclerosis, depression, epilepsy, and asthma.